InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Suri Anish, Président et Directeur Scientifique. Insider active across 1 company, notably Cue Biopharma, Inc.. Cumulatively, 6 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €10k. Activity tracked since 23 September 2021. The latest transaction was filed on 25 August 2023 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Anish Suri is the President and Chief Scientific Officer at Cue Biopharma, Inc. He leads the company's research and development efforts, focusing on innovation in the field of biotherapies. His scientific expertise is crucial for the development of new therapeutic solutions and for the strategic direction of the company.